The role of RNA splicing factors in Ras transformed cells
The role of RNA splicing factors in Ras transformed cells
批准号:
9153892
负责人:
Ji Luo
金额:
$19.1万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
背景。通过shRNA合成致死筛选,我们已经确定了KRAS突变癌细胞生存所需的一些mRNA剪接因子。目的。在这个项目中,我们的目标是解决以下问题:1)mRNA剪接因子的缺失导致KRAS癌基因合成致死的机制;2)哪些细胞mrna在KRAS突变细胞中被差异剪接;3)与KRAS野生型细胞相比,KRAS突变细胞mRNA剪接模式的变化如何影响其生存能力。重要的材料和方法。1)靶向剪接因子的shrna。2)定量mRNA剪接模式变化的RNA-seq方案。的成就。我们已经确定了一种新的机制,通过这种机制,KRAS基因的剪接是由外显子连接复合物调节的。一份描述我们发现的手稿正在审查中,准备发表。
英文摘要
BACKGROUND. Through a shRNA synthetic lethal screen we have identified a number of mRNA splicing factors that are required for the viability of KRAS mutant cancer cells. PURPOSE. In this project we aim to address the following questions: 1) the mechanism by which depletion of mRNA splicing factors causes synthetic lethality with the KRAS oncogene; 2) which cellular mRNAs are differentially spliced in KRAS mutant cells; 3) how the changes in mRNA splicing pattern in KRAS mutant cells affect their viability compared to KRAS wild type cells. SIGNIFICANT MATERIALS AND METHODS. 1) shRNAs that target splicing factors. 2) RNA-seq protocol for quantifying mRNA splicing pattern changes. ACCOMPLISHMENT. We have identified a novel mechanism by which the splicing of the KRAS gene is regulated by the exon junction complex. A manuscript describing our finding is under review for publication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alternative splicing in Ras transformed cells
-
批准号:8553150
-
项目类别:
-
资助金额:$13.47万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Ras oncogene induced protein SUMOylation changes
-
批准号:8553092
-
项目类别:
-
资助金额:$13.47万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Effect of the Ras oncogene on genomic stability
-
批准号:8349430
-
项目类别:
-
资助金额:$14.14万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Ras oncogene induced protein SUMOylation changes
-
批准号:8349456
-
项目类别:
-
资助金额:$14.14万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Pooled shRNA screens for target discoveries in cancer
-
批准号:9153918
-
项目类别:
-
资助金额:$14.32万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Non-oncogene addiction in cancer cells
-
批准号:10702519
-
项目类别:
-
资助金额:$47.35万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Target discovery and combination therapy in KRAS mutant cancer
-
批准号:10702641
-
项目类别:
-
资助金额:$47.35万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Factors that influence age-dependent Ras mutant cancer development in mice
-
批准号:10926544
-
项目类别:
-
资助金额:$32.74万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Discovery of combination therapy for KRAS mutant cancer
-
批准号:10262424
-
项目类别:
-
资助金额:$28.31万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Genetic screens for target discovery in cancer
-
批准号:10486849
-
项目类别:
-
资助金额:$32.02万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Discovery of combination therapy for KRAS mutant cancer
-
批准号:10486940
-
项目类别:
-
资助金额:$32.02万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Screen for Ras inhibitors
-
批准号:8553091
-
项目类别:
-
资助金额:$4.49万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Methods for mammalian genetic analysis
-
批准号:9556518
-
项目类别:
-
资助金额:$10.04万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Role of the protein SUMOylation pathway in Ras-driven oncogenesis
-
批准号:9153853
-
项目类别:
-
资助金额:$19.1万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Discovery of combination therapy for KRAS mutant cancer
-
批准号:9556706
-
项目类别:
-
资助金额:$20.07万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
New shRNA vectors for mammalian genetic analysis
-
批准号:8763444
-
项目类别:
-
资助金额:$13.22万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Screen for Ras inhibitors
-
批准号:8349455
-
项目类别:
-
资助金额:$10.6万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
New shRNA vectors for mammalian genetic analysis
-
批准号:8349457
-
项目类别:
-
资助金额:$14.14万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Methods for mammalian genetic analysis
-
批准号:10926177
-
项目类别:
-
资助金额:$21.83万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
Mechanism of anchorage independent growth driven by the KRAS oncogene
-
批准号:10262425
-
项目类别:
-
资助金额:$28.31万
-
财政年份:--
-
负责人:Ji Luo
-
依托单位:
海外基金